Alluvi Healthcare supplies retatrutide in two pen formats — the 20mg and the 40mg pre-filled research device. Choosing between them depends on your research protocol, dose-response objectives, and the phase of investigation. This guide covers the differences in detail.
| Spec | Retatrutide 20mg Pen | Retatrutide 40mg Pen |
|---|---|---|
| Total peptide per pen | 20mg | 40mg |
| Doses per pen | 4 doses of 5mg | 4 doses of 10mg |
| Format | Pre-filled, ready to use | Pre-filled, ready to use |
| Batch | AR0763RT4 | AR0763RT4 |
| Purity | 99.38% HPLC | 99.38% HPLC |
| Single price | £125 | £195 |
| COA included | Yes — Janoshik | Yes — Janoshik |
The 20mg pen (4 × 5mg doses) is ideal for dose-escalation titration studies, where starting at lower concentrations and incrementally increasing allows researchers to document threshold responses, receptor saturation curves and dose-dependent efficacy patterns. The 5mg dose increment provides finer control for these protocols.
If your research objective is to establish dose-response relationships — mapping receptor activity across a range of concentrations — the 20mg pen provides the lower end of the concentration range needed for a complete dose-response curve when paired with the 40mg format.
For extended research protocols requiring sustained lower-concentration exposure over time, the 20mg pen or the x2 bundle (£169.99) provides more doses per unit cost at the 5mg level.
The 40mg pen (4 × 10mg doses) is suited to research focused on maximal receptor agonism — understanding the ceiling effect, tri-receptor saturation (GLP-1/GIP/Glucagon) and peak metabolic modulation. Phase 2 clinical data used 12mg weekly as the highest dose in human studies, making the 10mg research dose relevant to this investigation range.
When comparing retatrutide against tirzepatide or semaglutide in parallel research protocols, the 40mg pen's higher dose range enables equivalent or higher receptor engagement for direct mechanistic comparison.
Yes — many research programmes use both formats. A common approach is to begin dose-escalation with the 20mg pen and progress to the 40mg format once lower-dose response is established. The Retatrutide 40mg x2 Bundle (£320) and 20mg x2 Bundle (£169.99) are designed for exactly this kind of extended protocol.
| Format | Price | Per mg |
|---|---|---|
| Retatrutide 20mg single | £125 | £6.25/mg |
| Retatrutide 20mg x2 Bundle | £169.99 | £4.25/mg |
| Retatrutide 40mg single | £195 | £4.88/mg |
| Retatrutide 40mg 3-pack | £510 | £4.25/mg |
| Retatrutide 40mg 10-pack | £1,500 | £3.75/mg |
The 40mg format offers better value per milligram at all quantity levels. The 20mg pen's advantage is the smaller dose increment — 5mg vs 10mg — which is specifically useful for titration and precision dose-response protocols.
Alluvi Healthcare supplies independently verified research peptides with full COA, cold chain delivery and UK-based support. Batch AR0763RT4 — 99.38% purity.